triMSx educational meeting, April 2020
This event focused on disease management and treatment in people with MS during the COVID-19 pandemic, with a focus on the following topics:
The programme included short talks from experts around the globe followed by a panel discussion and Q&A session.
triMS.online would like to acknowledge F. Hoffmann-La Roche for providing an unrestricted educational grant for this triMSx COVID-19 event.
00:00:00 | Introduction Gavin Giovannoni, UK |
00:02:34 | What do we know about COVID-19 virology and epidemiology? Marco Salvetti, Italy |
00:22:34 | Where next for COVID-19 public health measures and timelines for treatment? Tony Cunningham, Australia |
00:43:01 | MS disease-modifying therapies - Immunosuppression and COVID-19 Tomas Kalincik, Australia |
00:58:00 | MS disease-modifying therapies – How to use DMTs during the COVID-19 pandemic Eva Havrdová, Czech Republic |
01:09:28 | MS services during the COVID-19 pandemic – Remote management of MS Anneke van der Walt, Australia |
01:24:13 | MS services during the COVID-19 pandemic MS self-monitoring and global data sharing (MS Data Alliance) Liesbet Peeters, Belgium |
01:34:09 | Leadership and Innovation in a time of crisis- creating new pathways for blood monitoring Bernadette Porter, UK |
01:42:00 | Q&A. Panel |
02:05:26 | Conclusion and thanks Gavin Giovannoni, UK |
19:00 |
Welcome and introductionProf. Gavin Giovannoni, UK |
19:05 |
What do we know about COVID-19 virology and epidemiology?
Prof. Marco Salvetti, Italy |
19:20 |
Where next for COVID-19 public health measures and timelines for treatment?
Prof. Tony Cunningham, Australia |
19:35 |
MS disease-modifying therapies
Associate Prof. Tomas Kalincik, Australia |
19:50 |
MS disease-modifying therapies
Prof. Eva Havrdová, Czech Republic |
20:05 |
MS services during the COVID-19 pandemic
Associate Prof. Anneke van der Walt, Australia |
20:15 |
MS services during the COVID-19 pandemic
Dr. Liesbet M Peeters, Belgium |
20:25 |
Leadership and Innovation in a time of crisis- creating new pathways for blood monitoring
Ms Bernadette Porter, UK |
20:40 |
Expert panel discussion and Q&AAll |
21:00 |
Meeting close |
Q&As0.49MB PDF |
|
Speaker biographies0.8MB PDF |